Co-investigator on GSBTM funded major research project titled “Repositioning Doxycyline as Anti-Cancer Therapy and Exploring its Synergy with extracellular ATP manipulation in Breast Cancer: Pre-Clinical and Early Clinical Exploration” worth 53,35,896/-.
Co-investigator on GSBTM funded major research project titled “Repositioning Doxycyline as Anti-Cancer Therapy and Exploring its Synergy with extracellular ATP manipulation in Breast Cancer: Pre-Clinical and Early Clinical Exploration” worth 53,35,896/-.
Admissions to the University are strictly based on merit and in accordance with approved policies and procedures.
No individual within or outside the University, nor any agent or agency, is authorized to influence admission decisions in exchange for money, favors, or any other consideration. Applicants and parents are strongly advised not to entertain or respond to any such appeals.
If you receive any communication seeking payment or promising admission, please report it immediately to:
